Asian lung cancer therapy studied
Wednesday, September 17, 2008 - 10:07
in Health & Medicine
HONG KONG, Sept. 17 (UPI) -- Chinese medical scientists say the drug gefitinib (Iressa) should be considered the first-line therapy for non-smoking Asian patients with lung cancer.
Read the whole article on UPI
More from UPI
Related
- Study establishes role for gefitinib in Asian nonsmokers with lung cancerTue, 16 Sep 2008, 10:44:17 EDT
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST
- Molecule plays early role in nonsmoking lung cancerMon, 27 Jul 2009, 13:29:50 EDT
- Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyFri, 16 May 2008, 11:22:13 EDT
- Study examines lung cancer among lifelong nonsmokersTue, 9 Sep 2008, 5:08:01 EDT